表紙
市場調查報告書

疫苗的開發與生產趨勢,新型冠狀病毒感染疾病 (COVID-19) 及其他疫苗的開發平台

Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

出版商 Kalorama Information 商品編碼 933194
出版日期 內容資訊 英文 182 Pages
商品交期: 最快1-2個工作天內
價格
疫苗的開發與生產趨勢,新型冠狀病毒感染疾病 (COVID-19) 及其他疫苗的開發平台 Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
出版日期: 2020年04月20日內容資訊: 英文 182 Pages
簡介

疫苗市場,由於開發中的疫苗數,和新型冠狀病毒感染疾病 (COVID-19) 疫苗的強烈要求,今後5年預計大幅增加。隨著在全世界COVID-19大爆發進行,企業挑戰這個難題,為提供疫苗的可能性奮鬥。

本報告提供人體疫苗市場相關調查分析,以商品化的疫苗和開發中的疫苗為焦點,疫苗廠商所面對的課題等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 疫苗產業的簡介

  • 概要
    • 疫苗的結構
    • 疫苗的種類
    • 法規流程

第3章 疫苗開發的生產與課題

  • 疫苗開發計劃
    • 由卵生產
    • 從細胞生產
  • 流感疫苗的生產
  • 細胞為基礎的流感疫苗
  • 製造上的課題
  • 大流行病
  • 受託製造的參與

第4章 疫苗產業的問題與趨勢

  • 概要
  • 平均壽命的提高
  • 製造獎勵
  • 合成疫苗
  • 人工智能 (AI) 開發
  • 開發平台和COVID-19開發

第5章 市場參與企業

  • ADVAXIS, INC
  • BAVARIAN NORDIC, A/S
  • BHARAT BIOTECH INTERNATIONAL LTD
  • CSL LIMITED/SEQIRIS
  • EMERGENT BIOSOLUTIONS, INC
  • GLAXOSMITHKLINE, INC
  • GRADALIS, INC
  • HAWAII BIOTECH, INC
  • IMMUNE RESPONSE BIOPHARMA, INC
  • NOVIO PHARMACEUTICALS, INC
  • JOHNSON & JOHNSON/CRUCELL/JANSSEN
  • MEDICAGO, INC
  • MERCK & CO, INC
  • 田邊三菱製藥
  • MODERNA, INC
  • NORTHWEST BIOTHERAPEUTICS, INC
  • NOVAVAX, INC
  • PFIZER, INC
  • SANOFI PASTEUR
  • SERUM INSTITUTE, INC
  • SOLIGENIX, INC
  • SOTIO A.S
  • 武田藥品工業
  • VALNEVA SE

附錄:WHO疫苗開發平台追蹤

目錄
Product Code: 20-029

The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of the demanding tasks that are facing vaccine manufacturers. “Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline” provides the following market data:

  • Worldwide Vaccine Market Revenues, 2019-2024
  • Global Vaccine Market Analysis by Country, 2019 (US, EU, Japan, China, India, RoW)
  • Major Manufacturers' Shares of the World Vaccine Market, 2019

This report examines the current global market for vaccines, including discussion of prevailing issues:

  • COVID-19 Vaccine Candidates
  • Developing World WHO Vaccine Candidates
  • Other Future Vaccine Products
  • Challenges to Vaccine Development

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, developing nations have not benefited as much from the introduction of vaccines. “Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline” outlines the issues and trends affecting the vaccine industry, including:

  • Increasing Life Expectancy
  • Manufacturing Incentives
  • Synthetic Vaccines
  • Artificial Intelligence Development
  • Pipeline and COVID-19 Development

The report also reviews the history and lines of business, strategic alliances and vaccine products of market participants:

  • Advaxis, Inc.
  • Bavarian Nordic, A/S
  • Bharat Biotech International Ltd.
  • CSL Limited/Seqiris
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline, Inc. (GSK)
  • Gradalis, Inc.
  • Hawaii Biotech, Inc.
  • Immune Response Biopharma, Inc.
  • Inovio, Inc.
  • Johnson & Johnson (J&J)/Crucell/Janssen
  • Medicago, Inc.
  • Merck, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Moderna, Inc
  • Northwest Biotherapeutics, Inc.
  • NovaVax, Inc.
  • Pfizer, Inc.
  • Sanofi Pasteur
  • Serum Institute, Inc.
  • Soligenix, Inc.
  • SOTIO a.s.
  • Takeda Pharmaceutical Co, Ltd.
  • Valneva SE

Also included as an appendix is the WHO Vaccine Pipeline Tracker, a listing of WHO vaccine candidates for HIV, Ebola/Marburg, Zika, Malaria, TB and Dengue - over 400 vaccines in development.

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
  • SCOPE AND METHODOLOGY
  • COVID-19
    • Table 1-1: Select Vaccines in Development for COVID-19
  • MARKET OVERVIEW AND POTENTIAL
    • Table 1-2: Total Worldwide Vaccine Market Revenues 2019-2024 (in billions $)
    • Table 1-3: Global Vaccine Market Analysis by Country, 2019 (in billions USD) (US, EU, Japan, China, India, RoW)
    • Table 1-4: Major Manufacturers' Shares of the World Vaccine Market, 2019 (%, $ Billions)

CHAPTER 2: INTRODUCTION TO VACCINE INDUSTRY

  • OVERVIEW
    • How Vaccines Work
    • Types of Vaccines
      • Table 2-1: Types of Vaccines
    • Regulatory Process

CHAPTER 3: PRODUCTION AND CHALLENGES OF VACCINE DEVELOPMENT

  • VACCINE DEVELOPMENT PROGRAM
    • Egg Production
    • Cellular Production
  • INFLUENZA VACCINE PRODUCTION
  • CELL-BASED INFLUENZA VACCINES
  • MANUFACTURING CHALLENGES
  • PANDEMICS
    • HIN1 Pandemic of 2009/2010
    • Coronavirus Pandemic
  • CONTRACT MANUFACTURING INVOLVEMENT

CHAPTER 4: ISSUES AND TRENDS OF THE VACCINE INDUSTRY

  • OVERVIEW
  • INCREASING LIFE EXPECTANCY
  • MANUFACTURING INCENTIVES
  • SYNTHETIC VACCINES
  • ARTIFICIAL INTELLIGENCE DEVELOPMENT
  • PIPELINE AND COVID-19 DEVELOPMENT
    • Table 4-1: Selected Vaccines in Development
    • Phase III Vaccine Trials: Status
    • Personalized Vaccines
      • Table 4-2: Selected Personalized Phase 1 and 2 Vaccine Trials 2020
    • COVID-19 Development
    • Table 4-3: Select Vaccines in Development for COVID-19

CHAPTER 5: MARKET PARTICIPANTS

  • ADVAXIS, INC
    • Table 5-1: Advaxis Corporate Summary
    • Company Summary
    • Products
  • BAVARIAN NORDIC, A/S
    • Table 5-2: Bavarian Nordic A/S Corporate Summary
    • Company Summary
    • Products
  • BHARAT BIOTECH INTERNATIONAL LTD
    • Table 5-3: Bharat Biotech Corporate Summary
    • Company Summary
  • CSL LIMITED/SEQIRIS
    • Table 5-4: CSL/Seqiris Corporate Summary
    • Company Summary
    • Products
  • EMERGENT BIOSOLUTIONS, INC
    • Table 5-5: Emergent BioSolutions Corporate Summary
    • Company Summary
    • Products
  • GLAXOSMITHKLINE, INC
    • Table 5-6: GlaxoSmithKline Corporate Summary
    • Company Summary
    • Products
      • Table 5-7: GSK Marketed Vaccines 2019
  • GRADALIS, INC
    • Table 5-8: Gradalis Corporate Summary
    • Company Summary
    • Products
  • HAWAII BIOTECH, INC
    • Table 5-9: Hawaii Biotech Corporate Summary
    • Company Summary
    • Products
  • IMMUNE RESPONSE BIOPHARMA, INC
    • Table 5-10: Immune Response Biopharma Corporate Summary
    • Company Summary
    • Products
  • INOVIO PHARMACEUTICALS, INC
    • Table 5-11: Inovio Corporate Summary
    • Company Summary
    • Products
  • JOHNSON & JOHNSON/CRUCELL/JANSSEN
    • Table 5-12: Johnson & Johnson Corporate Summary
    • Company Summary
    • Products
  • MEDICAGO, INC
    • Table 5-13: Medicago Corporate Summary
    • Company Summary
    • Products
  • MERCK & CO, INC
    • Table 5-14: Merck Corporate Summary
    • Company Summary
    • Products
  • MITSUBISHI TANABE PHARMA CORPORATION
    • Table 5-15: Mitsubishi Tanabe Corporate Summary
    • Company Summary
    • Products
  • MODERNA, INC
    • Table 5-16: Moderna Corporate Summary
    • Company Summary
    • Products
  • NORTHWEST BIOTHERAPEUTICS, INC
    • Table 5-17: Northwest BioTherapeutics Corporate Summary
    • Company Summary
    • Products
  • NOVAVAX, INC
    • Table 5-18: NovaVax Corporate Summary
    • Company Summary
    • Products
  • PFIZER, INC
    • Table 5-19: Pfizer Corporate Summary
    • Company Summary
    • Products
  • SANOFI PASTEUR
    • Table 5-20: Sanofi Pasteur Corporate Summary
    • Company Summary
    • Products
  • SERUM INSTITUTE, INC
    • Table 5-21: Serum Institute of India Corporate Summary
    • Company Summary
    • Products
  • SOLIGENIX, INC
    • Table 5-22: Soligenix Corporate Summary
    • Company Summary
    • Products
  • SOTIO A.S
    • Table 5-23: SOTIO Corporate Summary
    • Company Summary
    • Products
  • TAKEDA PHARMACEUTICAL CO, LTD
    • Table 5-24: Takeda Pharmaceutical Corporate Summary
    • Company Summary
    • Products
  • VALNEVA SE
    • Table 5-25: Valneva Corporate Summary
    • Company Summary
    • Products

APPENDIX: WHO VACCINE PIPELINE TRACKER

  • Table A-1: WHO Vaccine Pipeline Tracker